Stage IIIB Breast Cancer Recruiting Phase 1 / 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01697293Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerTreatment